Splenic Irradiation in Chronic Myeloid Leukemia

Splenic Irradiation in Chronic Myeloid Leukemia

Results of splenic irradiation as the initial and only method of treatment are reported in 25 patients with chronic myeloid leukemia. Peripheral remission was induced in all the patients. Induction was achieved after a short period of 11 to 30 days in the majority of the patients, the longest period...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta Radiologica: Oncology 1983, Vol.22 (1), p.9-12
Hauptverfasser: Hukku, S., Baboo, H. A., Venkataratnam, S., Vidyasagar, M. S., Patel, N. L.
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Busulfan - therapeutic use
Humans
Leukemia, Myeloid - drug therapy
Leukemia, Myeloid - radiotherapy
Radiotherapy Dosage
Spleen - radiation effects
Time Factors
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 12
container_issue 1
container_start_page 9
container_title Acta Radiologica: Oncology
container_volume 22
creator Hukku, S.
Baboo, H. A.
Venkataratnam, S.
Vidyasagar, M. S.
Patel, N. L.
description Results of splenic irradiation as the initial and only method of treatment are reported in 25 patients with chronic myeloid leukemia. Peripheral remission was induced in all the patients. Induction was achieved after a short period of 11 to 30 days in the majority of the patients, the longest period being 40 days. Several patients were in remission 9 months after treatment. The results are compared with those obtained by chemotherapy. Some advantages of splenic irradiation over chemotherapy are emphasized.
doi_str_mv 10.3109/02841868309134332
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_informahealthcare_journals_10_3109_02841868309134332</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80510338</sourcerecordid><originalsourceid>FETCH-LOGICAL-c461t-4505d359e99926bed45d4c4ddacfbfd0ef04567cb3cd91c61ced85c170d0c9e63</originalsourceid><addsrcrecordid>eNp9kM1Lw0AQxRdRaq3-AR6EnLzFzmY_msWTFD8KFQ8q9BY2uxO6NcnW3eTQ_96UFi-Cp4H5vfeYeYRcU7hjFNQUspzTXOYMFGWcseyEjKkUNM0yuTol4z1PB8HqnFzEuAGAjM3EiIwkA0E5jMn0fVtj60yyCEFbpzvn28S1yXwd_H79usPaO5sssf_CxulLclbpOuLVcU7I59Pjx_wlXb49L-YPy9RwSbuUCxCWCYVKqUyWaLmw3HBrtanKygJWwIWcmZIZq6iR1KDNhaEzsGAUSjYht4fcbfDfPcauaFw0WNe6Rd_HIh_uB8byQUgPQhN8jAGrYhtco8OuoFDsSyr-lDR4bo7hfdmg_XUcWxn4_YG7tvKh0WvUdbc2OmCx8X1oh8f_Sf8BCKVzpA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80510338</pqid></control><display><type>article</type><title>Splenic Irradiation in Chronic Myeloid Leukemia</title><source>MEDLINE</source><source>Taylor &amp; Francis:Master (3349 titles)</source><creator>Hukku, S. ; Baboo, H. A. ; Venkataratnam, S. ; Vidyasagar, M. S. ; Patel, N. L.</creator><creatorcontrib>Hukku, S. ; Baboo, H. A. ; Venkataratnam, S. ; Vidyasagar, M. S. ; Patel, N. L.</creatorcontrib><description>Results of splenic irradiation as the initial and only method of treatment are reported in 25 patients with chronic myeloid leukemia. Peripheral remission was induced in all the patients. Induction was achieved after a short period of 11 to 30 days in the majority of the patients, the longest period being 40 days. Several patients were in remission 9 months after treatment. The results are compared with those obtained by chemotherapy. Some advantages of splenic irradiation over chemotherapy are emphasized.</description><identifier>ISSN: 0284-186X</identifier><identifier>ISSN: 0349-652X</identifier><identifier>EISSN: 1651-226X</identifier><identifier>DOI: 10.3109/02841868309134332</identifier><identifier>PMID: 6305140</identifier><language>eng</language><publisher>Sweden: Informa UK Ltd</publisher><subject>Adult ; Busulfan - therapeutic use ; Humans ; Leukemia, Myeloid - drug therapy ; Leukemia, Myeloid - radiotherapy ; Radiotherapy Dosage ; Spleen - radiation effects ; Time Factors</subject><ispartof>Acta Radiologica: Oncology, 1983, Vol.22 (1), p.9-12</ispartof><rights>1983 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 1983</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c461t-4505d359e99926bed45d4c4ddacfbfd0ef04567cb3cd91c61ced85c170d0c9e63</citedby><cites>FETCH-LOGICAL-c461t-4505d359e99926bed45d4c4ddacfbfd0ef04567cb3cd91c61ced85c170d0c9e63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.3109/02841868309134332$$EPDF$$P50$$Ginformahealthcare$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.3109/02841868309134332$$EHTML$$P50$$Ginformahealthcare$$H</linktohtml><link.rule.ids>314,780,784,4024,27923,27924,27925,61221,61402</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6305140$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hukku, S.</creatorcontrib><creatorcontrib>Baboo, H. A.</creatorcontrib><creatorcontrib>Venkataratnam, S.</creatorcontrib><creatorcontrib>Vidyasagar, M. S.</creatorcontrib><creatorcontrib>Patel, N. L.</creatorcontrib><title>Splenic Irradiation in Chronic Myeloid Leukemia</title><title>Acta Radiologica: Oncology</title><addtitle>Acta Radiol Oncol</addtitle><description>Results of splenic irradiation as the initial and only method of treatment are reported in 25 patients with chronic myeloid leukemia. Peripheral remission was induced in all the patients. Induction was achieved after a short period of 11 to 30 days in the majority of the patients, the longest period being 40 days. Several patients were in remission 9 months after treatment. The results are compared with those obtained by chemotherapy. Some advantages of splenic irradiation over chemotherapy are emphasized.</description><subject>Adult</subject><subject>Busulfan - therapeutic use</subject><subject>Humans</subject><subject>Leukemia, Myeloid - drug therapy</subject><subject>Leukemia, Myeloid - radiotherapy</subject><subject>Radiotherapy Dosage</subject><subject>Spleen - radiation effects</subject><subject>Time Factors</subject><issn>0284-186X</issn><issn>0349-652X</issn><issn>1651-226X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1Lw0AQxRdRaq3-AR6EnLzFzmY_msWTFD8KFQ8q9BY2uxO6NcnW3eTQ_96UFi-Cp4H5vfeYeYRcU7hjFNQUspzTXOYMFGWcseyEjKkUNM0yuTol4z1PB8HqnFzEuAGAjM3EiIwkA0E5jMn0fVtj60yyCEFbpzvn28S1yXwd_H79usPaO5sssf_CxulLclbpOuLVcU7I59Pjx_wlXb49L-YPy9RwSbuUCxCWCYVKqUyWaLmw3HBrtanKygJWwIWcmZIZq6iR1KDNhaEzsGAUSjYht4fcbfDfPcauaFw0WNe6Rd_HIh_uB8byQUgPQhN8jAGrYhtco8OuoFDsSyr-lDR4bo7hfdmg_XUcWxn4_YG7tvKh0WvUdbc2OmCx8X1oh8f_Sf8BCKVzpA</recordid><startdate>1983</startdate><enddate>1983</enddate><creator>Hukku, S.</creator><creator>Baboo, H. A.</creator><creator>Venkataratnam, S.</creator><creator>Vidyasagar, M. S.</creator><creator>Patel, N. L.</creator><general>Informa UK Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1983</creationdate><title>Splenic Irradiation in Chronic Myeloid Leukemia</title><author>Hukku, S. ; Baboo, H. A. ; Venkataratnam, S. ; Vidyasagar, M. S. ; Patel, N. L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c461t-4505d359e99926bed45d4c4ddacfbfd0ef04567cb3cd91c61ced85c170d0c9e63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><topic>Adult</topic><topic>Busulfan - therapeutic use</topic><topic>Humans</topic><topic>Leukemia, Myeloid - drug therapy</topic><topic>Leukemia, Myeloid - radiotherapy</topic><topic>Radiotherapy Dosage</topic><topic>Spleen - radiation effects</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hukku, S.</creatorcontrib><creatorcontrib>Baboo, H. A.</creatorcontrib><creatorcontrib>Venkataratnam, S.</creatorcontrib><creatorcontrib>Vidyasagar, M. S.</creatorcontrib><creatorcontrib>Patel, N. L.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Acta Radiologica: Oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hukku, S.</au><au>Baboo, H. A.</au><au>Venkataratnam, S.</au><au>Vidyasagar, M. S.</au><au>Patel, N. L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Splenic Irradiation in Chronic Myeloid Leukemia</atitle><jtitle>Acta Radiologica: Oncology</jtitle><addtitle>Acta Radiol Oncol</addtitle><date>1983</date><risdate>1983</risdate><volume>22</volume><issue>1</issue><spage>9</spage><epage>12</epage><pages>9-12</pages><issn>0284-186X</issn><issn>0349-652X</issn><eissn>1651-226X</eissn><abstract>Results of splenic irradiation as the initial and only method of treatment are reported in 25 patients with chronic myeloid leukemia. Peripheral remission was induced in all the patients. Induction was achieved after a short period of 11 to 30 days in the majority of the patients, the longest period being 40 days. Several patients were in remission 9 months after treatment. The results are compared with those obtained by chemotherapy. Some advantages of splenic irradiation over chemotherapy are emphasized.</abstract><cop>Sweden</cop><pub>Informa UK Ltd</pub><pmid>6305140</pmid><doi>10.3109/02841868309134332</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0284-186X
ispartof Acta Radiologica: Oncology, 1983, Vol.22 (1), p.9-12
issn 0284-186X
0349-652X
1651-226X
language eng
recordid cdi_informahealthcare_journals_10_3109_02841868309134332
source MEDLINE; Taylor & Francis:Master (3349 titles)
subjects Adult
Busulfan - therapeutic use
Humans
Leukemia, Myeloid - drug therapy
Leukemia, Myeloid - radiotherapy
Radiotherapy Dosage
Spleen - radiation effects
Time Factors
title Splenic Irradiation in Chronic Myeloid Leukemia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T07%3A52%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Splenic%20Irradiation%20in%20Chronic%20Myeloid%20Leukemia&rft.jtitle=Acta%20Radiologica:%20Oncology&rft.au=Hukku,%20S.&rft.date=1983&rft.volume=22&rft.issue=1&rft.spage=9&rft.epage=12&rft.pages=9-12&rft.issn=0284-186X&rft.eissn=1651-226X&rft_id=info:doi/10.3109/02841868309134332&rft_dat=%3Cproquest_cross%3E80510338%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80510338&rft_id=info:pmid/6305140&rfr_iscdi=true